Skip to main content
. 2022 Nov;10(22):1228. doi: 10.21037/atm-22-5352

Figure 2.

Figure 2

Median OS times of pyrotinib and radiotherapy vs. pyrotinib-based therapy in the 2 groups. OS, overall survival; HR, hazard ratio; CI, confidence interval.